You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

Sickle Cell Disease, Multiple Myeloma Trial in Washington

Enrolling by invitation
  • Sickle Cell Disease
  • Multiple Myeloma
    • Washington, District of Columbia
      ASH Research Collaborative
    Mar 7, 2023

    Coronavirus Infection and Hematologic Diseases Trial in Russian Federation (Non-interventional study)

    Completed
    • Coronavirus Infection and Hematologic Diseases
    • Non-interventional study
    • Ekaterinburg, Russian Federation
    • +14 more
    Jan 25, 2023

    Screening for Hematology Branch Protocols

    Enrolling by invitation
    • Hematologic Disease and Disorders
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

      Recruiting
      • Acute Graft Versus Host Disease
      • Hematopoietic and Lymphoid System Neoplasm
      • Duarte, California
        City of Hope Medical Center
      Jan 5, 2023

      Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)

      Not yet recruiting
      • Pediatric Patients
      • +2 more
      • CliniMACS Plus Instrument
      • Aurora, Colorado
        Children's Hospital Colorado
      Jun 29, 2022

      Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

      Not yet recruiting
      • Chronic Graft-versus-Host-Disease
      • +4 more
        • (no location specified)
        Jan 11, 2023

        Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

        Recruiting
        • Hematologic Malignancy
        • Blood draw
        • Durham, North Carolina
          Duke University
        Jun 22, 2022

        Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

        Not yet recruiting
        • Graft Vs Host Disease
        • +5 more
        • CliniMACS® device
        • (no location specified)
        Jul 20, 2023

        Children With Chronic Kidney Disease

        Not yet recruiting
        • CKD
        • Hematological Disease
          • (no location specified)
          Nov 20, 2023

          Venous Thromboembolism in Hematologic Malignancy and

          Active, not recruiting
          • Thrombosis, Venous
          • +4 more
            • Toronto, Ontario, Canada
              Federico Carini
            Nov 21, 2022

            Acute Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma Trial (3D189)

            Recruiting
            • Acute Leukemia
            • +3 more
            • 3D189
            • Guangzhou, Guangdong, China
            • +3 more
            Jan 2, 2023

            (Proteomic and Genomic Analysis of Biospecimens)

            Enrolling by invitation
            • Oncology
            • +8 more
            • Observational Study Only. NO Intervention.
            • New Orleans, Louisiana
              AUD
            Jun 2, 2023

            Hematological Abnormalities in Children

            Not yet recruiting
            • Hematologic Diseases
            • sampling
            • (no location specified)
            Sep 14, 2022

            Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

            Not yet recruiting
            • Blood Disease
            • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
            • CliniMACS® System
            • (no location specified)
            Jan 30, 2023

            Blood Disease Trial (virtual reality, Physical Exercise)

            Not yet recruiting
            • Blood Disease
            • virtual reality
            • Physical Exercise
            • (no location specified)
            Jul 11, 2023

            Hematological Disorder in Patients With Angiodysplasia

            Not yet recruiting
            • Angiodysplasia
            • Hematological Disease
            • Von willebrand antigen
            • (no location specified)
            Sep 26, 2023

            Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

            Not yet recruiting
            • Multiple Myeloma
            • +2 more
            • Discontinuation of maintenance treatment
            • Cork, Ireland
              Cork University Hospital
            May 10, 2023

            Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

            Active, not recruiting
            • Hematologic Malignancy
            • Pavia, Italy
            • +2 more
            Jul 10, 2022

            HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

            Not yet recruiting
            • HIV
            • Hematologic Malignancies
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 17, 2022

            Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)

            Recruiting
            • Hematological Malignancies
            • Guangzhou, Guangdong, China
            • +2 more
            Aug 10, 2022

            Gulf Long-Term Follow-Up Study

            Active, not recruiting
            • Cardiovascular Disease
            • +4 more
              • Durham, North Carolina
                Social & Scientific Systems
              Aug 24, 2022

              Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

              Completed
              Has Results
              • Hematologic Malignancies
              • +2 more
              • Ann Arbor, Michigan
                University of Michigan Hospital
              Dec 3, 2021

              Hematologic Diseases, Anaemia, Sickle Cell Trial in Las Vegas (GSK4172239D, Placebo)

              Not yet recruiting
              • Hematologic Diseases
              • Anaemia, Sickle Cell
              • Las Vegas, Nevada
                GSK Investigational Site
              Jan 23, 2023

              MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

              Recruiting
              • Myelodysplastic Syndromes, de Novo
              • +10 more
              • Boston, Massachusetts
                Dana-Farber Cancer Institute
              Jan 23, 2023